pharma · Solid Tumors · Primary Dysmenorrhea
Topiloric/Uriadec
Topiloric/Uriadec is a pharma organization headquartered in SOUTH SAN FRANCISCO, CA, JP. Primary therapeutic focus areas include Solid Tumors, Primary Dysmenorrhea, Prostate cancer, chronic liver disease, Prostatic Neopl
SOUTH SAN FRANCISCO, CA, JP HQ
2 Employees
PMDA registrant Type
Company details
- Status
- Public
- HQ
- SOUTH SAN FRANCISCO, CA, JP
- Employees
- 2
- Programs
- 12
- Drugs
- 7
- Patents
- 52
ORIC-533
Phase 1 · small molecule · Relapsed or Refractory Multiple Myeloma
ORIC-533 for Relapsed or Refractory Multiple Myeloma is a Phase 1 program (small_molecule) at Topiloric/Uriadec with 1 ClinicalTrials.gov record(s).
Internal code ORIC-533-01
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Topiloric/Uriadec
- Phase
- Phase 1
- Modality
- small_molecule
- Indication
- Relapsed or Refractory Multiple Myeloma
- Status
- completed
- Trials
- 1